The United Kingdom’s National Institute for Health and Care Excellence has approved a once-a-day drug that is aimed at reducing the urge to drink.
Nalmefene, also called Selincro, is licensed for use alongside psychosocial support to help people reduce their alcohol consumption.
“Many people have a difficult relationship with alcohol even though they have a very stable lifestyle, maintain jobs and a social life and would not automatically assume they have a problem. But regularly drinking over the recommended daily amount of alcohol can seriously damage your health,” said Professor Carole Longson, NICE Health Technology Evaluation Centre Director. “When used alongside psychosocial support nalmefene is clinically and cost effective for the NHS compared with psychosocial support alone.”
Total alcohol consumption was also noted to have been reduced by 50 per cent with placebo and counseling and the number was cut by 61 per cent with pill and counseling. Nalmefene has been shown to cut alcohol consumption down by 61 per cent after six months alongside regular counseling sessions
Other articles you might be interested in…